the Lancet standing Commission Report: Dementia prevention, intervention, and care released
On Jul. 31, 2024, the Lancet Standing Commission released its 2024 Dementia prevention, intervention, and care report that…
Generation X and Millennials in U.S. Have Higher Risk of Developing 17 Cancers Compared to Older Generations
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
FDA approved Guardant Health’ Shield, a test to screen for colorectal cancer
On Jul. 26, 2024, the U.S. Food and Drug Administration (FDA) approved the Guardant Health’s Shield, a test…
Boar’s Head Recalls Ready-To-Eat Liverwurst And Other Deli Meat Products Due to Possible Listeria Contamination
On Jul. 26. 2024, Boar’s Head, a Jarratt, Va., establishment, announced it was recalling all liverwurst product produced…
European Commission Approves Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B
On Jul. 25, 2024, Pfizer announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX®…
Successful first-in-human implantation of the BiVACOR Total Artificial Heart by Baylor and THI doctors
On Jul. 25, 2024, doctors from the Texas Heart Institute (THI), BiVACOR®, Baylor St. Luke’s Medical Center and…
CIRM approved $8 million award for plasma cell disorder therapy, $27 million to boost collaboration among California researchers
On Jul. 25, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
Scientists identified possible new transmission factor in hospital-acquired Klebsiella infections
On Jul. 22, 2024, scientists at ADA Forsyth Institute (AFI) announced they had identified a critical factor that…
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
Public Health Officials Confirmed First Human Plague Case in Pueblo County, Colorado
On Jul. 9, 2024, officials at the Pueblo Department of Public Health and Environment (PDPHE), in collaboration with…
Study detected bacteria in 35% of commercial tattoos and permanent makeup inks sold in U.S.
On Jul. 2, 2024, a study was released that showed evidence that commercial tattoo and PMU inks are…
Biotechnology | Disease | Life Science News | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
Emergent BioSolutions Awarded $250+ Million in Contract to Supply U.S. Government with Four Critical Medical Countermeasure Products
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
Disease | Therapeutics | WHO
WHO releases first-ever clinical treatment guideline for tobacco cessation in adults
On Jul. 2, 2024, the World Health Organization (WHO) recommended a comprehensive set of tobacco cessation interventions, including…
CIRM awarded $26 million to advance clinical research across cancer, heart conditions, and rare diseases
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
Nearly 1.8 billion adults at risk of disease from not doing enough physical activity
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
Biotechnology | Disease | FDA | Life Science News | Medicine | Therapeutics
FDA Expanded Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy
On Jun. 20, 2024, the U.S. Food and Drug Administration expanded the approval of Sarepta Therapeutics’ Elevidys (delandistrogene…
Paralyzed mountain lion found in Colorado first case of “staggering disease” in North America
On Jul. 16, 2024, Colorado Parks and Wildlife officials announced the first finding of ‘rustrela virus’ in a…
How a few days in space can disrupt a person’s biology
On Jun. 12, 2024, scientists at Weill Cornell Medicine in New York City reported that just a few…
NIH launched $30 million pilot to test feasibility of a national primary care research network
On Jun. 6, 2024, the National Institutes of Health (NIH) announced it was investing approximately $30 million in…
Biogen received European Commission approval for QALSODY® (tofersen), first therapy for rare, genetic form of ALS
On May 30, 2024, Biogen announced that the European Commission (EC) had granted marketing authorization under exceptional circumstances…
Scientists unraveled genetic basis for neurodegenerative disorders that affect vision
On May 15, 2024, a team of scientists led by National Institutes of Health (NIH) researchers announced it…
American Association for Cancer Research released biennial Cancer Disparities Progress Report 2024
On May 15, 2024, the American Association for Cancer Research (AACR) released its biennial Cancer Disparities Progress Report…
Roche announced FDA approval of HPV self-collection solutions in the U.S. , expanding screening to help eliminate cervical cancer
On May 14, 2024, Roche announced the U.S. FDA approval of its human papillomavirus (HPV) self-collection solution, one…
Black history month
Black History Month Celebrates the pioneering accomplishments of James McCune Smith, Rebecca Lee Crumpler, Alexa Canady and Patricia…
Cartoons - Original | Cloning | Disease | HIV | Life Science History | Medicine | Oncology | Therapeutics | Women's Health
asian history month
Asian American and Pacific Islander History Month celebrates the scientific accomplishments of several firsts, from the first chemo…
Google DeepMind unveiled next generation of drug discovery AI model
On May 8, 2024, Google Deepmind announced it had unveiled the third major version of its “AlphaFold” artificial…
Diagnostics | Disease | Life Science News | Medical Device | Nanotechnology | Neurology | Non-Profit Research | Therapeutics
Imaging technique shows new details of peptide structures
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
California’s Stem Cell Agency awarded $56 million for clinical research, $21.3 million for Shared Labs program
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
FDA approved Xolair as first and only medicine for children and adults with one or more food allergies
On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…
Agriculture | Disease | Influenza | Life Science News | WHO
Avian influenza A(H10N5) and influenza A(H3N2) coinfection reported in China
On Jan. 27, 2024, the National Health Commission of the People’s Republic of China notified the World Health…